(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

AVIDAS PHARMACEUTICALS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

AVIDAS PHARMACEUTICALS

ST13

US500000077456718

Class

35

Filing

77456718

Registration

3870892

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

48

Latest update

08/20/2021

Classification

Registered

Trademark type

Word

Nice classes

35

Filing date

04/24/2008

Registration date

11/02/2010

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/20/2021

Last transaction

08/20/2021

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

10/01/2008

First use in commerce

10/01/2008

Drawing code

4

Owner type

16

Owner location

Doylestown, PA, US

Examiner

HESIK, APRIL ANNE

Law office

M40

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

AVIDAS PHARMACEUTICALS LLC

Representatives

Keith Lange Lange IP Law

Technical classification

Nice Classes

Class 35

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Marketing services in the pharmaceutical industrypromoting prescription and non-prescription products; advertising and marketing in the pharmaceutical industry; public relations in the pharmaceutical industry

Publications

History of USPTO decisions and trademark events.

48 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

08/20/2021

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

08/20/2021

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

08/20/2021

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

08/20/2021

E89R

TEAS SECTION 8 & 9 RECEIVED

04/30/2021

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

11/02/2019

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

06/22/2017

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

06/22/2017

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

06/22/2017

E815

TEAS SECTION 8 & 15 RECEIVED

04/28/2017

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

11/02/2015

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

01/19/2012

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

12/19/2011

R.PR

REGISTERED-PRINCIPAL REGISTER

11/02/2010

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

09/25/2010

REGV

LAW OFFICE REGISTRATION REVIEW COMPLETED

09/24/2010

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

09/22/2010

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/22/2010

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/22/2010

ALIE

ASSIGNED TO LIE

09/22/2010

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/09/2010

GSPS

NOTIFICATION OF SU - PRIORITY ACTION E-MAILED

03/10/2010

GSPR

SU - PRIORITY ACTION E-MAILED

03/10/2010

SPRA

SU - PRIORITY ACTION WRITTEN

03/10/2010

SUPC

STATEMENT OF USE PROCESSING COMPLETE

02/26/2010

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

02/26/2010

IUAF

USE AMENDMENT FILED

01/28/2010

EISU

TEAS STATEMENT OF USE RECEIVED

01/28/2010

NOAM

NOA MAILED - SOU REQUIRED FROM APPLICANT

07/28/2009

PUBO

PUBLISHED FOR OPPOSITION

05/05/2009

NPUB

NOTICE OF PUBLICATION

04/15/2009

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

03/30/2009

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/30/2009

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/26/2009

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/26/2009

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

03/26/2009

ALIE

ASSIGNED TO LIE

03/24/2009

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

09/22/2008

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

09/22/2008

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/19/2008

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

09/16/2008

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

09/10/2008

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

09/10/2008

GEAN

NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED

08/26/2008

GEAP

EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED

08/26/2008

CPEA

EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED

08/26/2008

DOCK

ASSIGNED TO EXAMINER

08/08/2008

NWAP

NEW APPLICATION ENTERED

04/28/2008

Continuous trademark protection

Get notified about every new filing that threatens AVIDAS PHARMACEUTICALS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.